ENT features
Per-Ingvar Brånemark: father of osseointegration
The application of osseointegration has been central to the development of both bone-anchored hearing aids and dental implants. But how did it all come about? Per-Ingvar Brånemark (1929–2014). Image Johan Wingborg. Many hearing-impaired patients owe a great debt of gratitude...
Jameel Muzaffar, Anne Schilder and James O’Hara
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...
Robert Vincent: otologie sans frontières
Chris Aldren speaks to French ear surgeon Robert Vincent who’s particularly proud of forming a global otologist network providing free resources for education and patient care worldwide. Robert Vincent Robert, who have been your otological mentors? I did my initial...
Young CEORL-HNS: empowering the future of otorhinolaryngology
Young CEORL-HNS is a subgroup within CEORL-HNS which encompasses new specialists in ENT within training and up to the first decade or so as an accredited specialist. Giuditta Mannelli is the current president and is a head and neck surgeon...
Confederation of European ORL Societies - your society!
Per Cayé-Thomasen is a professor of otology and skull base surgery in Copenhagen. In Milan, he succeeded Cem Meco as the president of the CEORL-HNS. Under his presidency, the confederation has continued to develop its educational activities and encourage professional...
Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai
We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...
Otolaryngologists and audiologists are invited to learn about and lead efforts to reduce the global burden of hearing loss
IFOS promises to be a multidimensional meeting, with contributions from speakers from all corners of the world covering a huge array of subjects. We hear about how the global health aspects of hearing loss will be covered in the congress....
Intratympanic steroids in Ménière's disease: what’s the evidence?
The days of drastic surgery for Ménière's disease are long gone. We know that intratympanic injections can deliver high doses of medication to the inner ear with minimal discomfort and minimal risk. But how do we choose from the myriad...
Genomic testing for deafness and its implications
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...
Lancet Commission on Hearing Loss
The Lancet Commission on Hearing Loss was convened in 2019, and its main report will be published in 2023. We learn more about it here. The Lancet Commission on Hearing Loss was convened in 2019, and was charged by Richard...
In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness
Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...
Otology training in low- and middle-income countries: a view from within
It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...
